• High trait anxiety is linked to altered hippocampal expression of CHD3 and CHD5.
being [1] . If anxiety goes beyond the normal emotional range and persists over extended periods of time thereby becoming trait-like and affecting the individual in a harmful rather than a protective way, it is classified as pathological anxiety (for review see Refs. [1, 2] ). Anxiety disorders comprise panic disorders, specific phobias and generalized anxiety disorders among others [3] and constitute the most prevalent disorders of the brain in Europe and the USA [4] . Thus, it is important to understand the mechanisms that lead to the development of persistent anxiety on a psychological as well as on a molecular level with the perspective of identifying potential biomarkers and/or the discovery of novel drug targets [2] . Anxiety disorders have a considerable component of heritability, and several vulnerability genes have been identified in patients including the serotonin transporter, the neuropeptide S receptor, catechol-O-methyltransferase, glyoxalase 1 and transmembrane protein 132D [5] . In agreement with these findings, altered expression of gene systems, such as the major inhibitory GABA system [6] , the neuropeptide S system [7] , the cell detoxification system [8] , transmembrane proteins [2] and the circadian clock gene Cry2 [9] , has been observed in a rodent model for trait anxiety. The mechanisms that are responsible for the observed defects in anxiety-related gene regulation, however, are poorly understood to date. On a fundamental level, the control of gene expression involves chromatin-modifying processes as important co-regulatory mechanisms. Chromatin, which is composed of DNA and histone proteins that are packaged in repeating units termed nucleosomes, generally precludes access of transcription factors to underlying DNA sequences. Various mechanisms that modify chromatin structure, including DNA methylation, histone modifications, histone variant incorporation, long noncoding RNA activity and ATP-dependent chromatin remodeling by ChRFs, serve to facilitate or to further restrict DNA access resulting in activation or repression of gene transcription [10] . Some of these mechanisms, in particular DNA methylation and histone acetylation and deacetylation, have been studied to some extent in different aspects of brain function and diseases, including neuropsychiatric disorders (for review see e.g. [11] [12] [13] [14] ). By contrast, comparatively little attention has been given to the roles of ChRFs in brain development, brain function and neurological and mood disorders, despite the fact that many ChRFs are highly expressed throughout the brain or in specific brain regions known to be involved in emotional processing [15] . In humans, ∼20 ATP-dependent chromatin remodeling factors belonging to several subfamilies are known, yet only a few of them have been studied in the context of the brain [12] . For example, in the recent past, clinical studies identified genetic associations of several ChRFs with intellectual and emotional disorders [12, 16] . In a previous study we have shown that protein expression levels of the CHD-family ChRFs CHD1, CHD3 and CHD5 were correlated with deficient fear extinction learning and its therapeutic rescue [15] . As increasing evidence suggests that chromatin-associated mechanisms are involved in mental and behavioral processes, a better understanding of the underlying programs and 'players' is necessary and might lead to the identification of targets for therapeutic interventions.
In light of the fact that trait anxiety involves considerable changes in gene expression programs [2] , we reasoned that altered ChRF expression levels might be involved in this process. To this end, we carried out a comparative analysis of protein and transcript levels of several ChRFs in different anxiety-linked brain areas of two mouse lines selectively bred for either high anxiety behavior (HAB) or normal anxiety-related behavior (NAB) [8] . HAB mice are considered to represent a model of the genetic risk factors of human anxiety disorders [2] . All mice used in this study were derived from the HAB and NAB lines generated by Landgraf and colleagues [8] and were bred in the animal facilities of the University of Innsbruck, Austria. The mice were group-housed under standard laboratory conditions (12 h light/dark cycle) with ad libitum access to tap water and pellet chow. The respective anxiety phenotypes of HAB and NAB animals were confirmed by an elevated plus maze test (EPM) at 7 weeks of age [9] . At 12 weeks of age, brains were removed from male HAB and NAB mice following CO 2 -euthanesia and bilateral tissue punches were collected from the medial prefrontal cortex, amygdala, dorsal and ventral hippocampus, hypothalamus and cerebellum and frozen in liquid nitrogen. The experiments were designed to minimize the number of animals used and were approved by the Austrian Animal Experimentation Ethics Board in compliance with international laws and policies.
To examine protein expression levels, we prepared nuclear extracts from the frozen tissue punches and performed western blot analysis exactly as described previously [15] . In the first set of experiments the samples from 2 to 4 animals of the same phenotype were pooled in order to be able to test the expression of several ChRFs, all of which have been shown to be involved in the expression of neuronal genes, brain development/function or cognitive processes [15, [17] [18] [19] [20] by semi-quantitative immunoblotting using antibodies against the following proteins: ATRX (Novus Biologicals NBP1-32851), the CHD-subfamily members CHD1 (Proteintech 20576-1-AP), CHD3 (Cell Signaling 4241S) and CHD5 [17] and the ISWI-subfamily member SNF2H (Abcam AB3749). For the relative quantification of protein signals on western blots, we normalized the intensity values of individual ChRF signals against signals of the nuclear factor TATA-box binding protein (TBP), a component of the three major transcriptional machineries RNA polymerase I, II and III and widely used loading control (Millipore 05-1531) using Image Studio Lite software (LI-COR Biosciences). All data in this study were analyzed by applying a two-tailed unpaired t-test using GraphPad Prism 6.0 software with a statistical significance set at p < 0.05.
These experiments revealed that in most of the tested brain areas ChRF levels were similar in HAB and NAB mice (Table 1) . However, there were three notable exceptions: In the amygdala of HAB mice, protein levels of SNF2H were lower than in NAB mice (Fig. 1A , Table 1 ). Furthermore, in the ventral hippocampus of HAB mice, CHD3 protein levels were decreased, while CHD5 levels were increased relative to NAB mice (Fig. 1B, C , Table 1 ). To corroborate these observations, we used brain area-specific tissue punches from individual 12-week old male animals (n = 4 per group) for western blotting. In line with the first set of experiments involving pooled tissues samples, HAB mice displayed decreased protein levels of SNF2H in the amygdala (−49.7%; p = 0.020; Fig. 1D ) and of CHD3 in the ventral hippocampus (−42.8%, p = 0.015; Fig. 1E ) as compared to NAB mice, while CHD5 protein expression was increased (+130%; p = 0.024; Fig. 1F ) in the ventral hippocampus. We further performed correlation analysis of protein signal intensities versus the percentage of time spent on the open arms of the EPM as marker of anxiety-related behavior. We found strong and significant correlation between anxiety-like behavior and SNF2H (r = 0.83, p = 0.01), CHD3 (r = 0.71, p = 0.049) and CHD5 (r = −0.81, p = 0.02) (Fig. 2) further strengthening the results from Fig. 1 .
In order to test, if the observed differences in protein levels of SNF2H, CHD3 and CHD5 were the result of altered transcription activity at the respective genes, we isolated RNA from the amygdala and ventral hippocampus of HAB and NAB mice for qPCR analysis according to the method described previously [15] using primers specific for Snf2h, Chd3, Chd5 and Gapdh as a normalization control (primer sequences available on request). We found a moderate, albeit not significant downregulation of amygdaloid Snf2h in HAB mice as compared with NAB mice (n = 10; p = 0.124) (Fig. 1G) . Neither the expression of Chd3 (n = 4; p = 0.639) nor the expression of Chd5 (n = 4; p = 0.711) differed in the ventral hippocampus of the two lines (Fig. 1H, I ). These results suggest that changes in protein stability rather than in transcriptional activity are responsible for the observed differences in HAB and NAB mice.
CHD3 and CHD5 are typical components of large remodeling complexes termed NuRD or NuRD-like complexes [17, 21] . Notably, a recent study reported that overexpression of CHD5 in a neuroblastoma cell line resulted in decreased protein, but not mRNA levels of CHD4, which is closely related to CHD3 and also a component of a NuRD-like complex. The authors suggested that CHD4 and CHD5 might compete for binding to the NuRD complex and that replacement of one protein by the other will lead to instability of the replaced protein [22] . Our finding of inverse regulation of CHD3 and CHD5 protein, but not mRNA levels in the ventral hippocampus is in good agreement with this hypothesis. Interestingly, we (A-F) . mRNA expression levels (mean ± SEM) of Snf2h (n = 10) in the amygdala (G), of Chd3 (n = 4) (H) and of Chd5 (n = 4) (I) in the vHC showed no significant differences between HAB mice compared to NAB animals. Data are presented as mean ± SEM. * p < 0.05. observed opposing regulation of CHD3 and CHD5 in the ventral hippocampus also during fear extinction learning [15] . Thus, it is possible that, in the context of fear and anxiety processing, the ventral hippocampus is particularly sensitive to the relative amounts of CHD3-versus CHD5-containing NuRD complexes and that a shift towards CHD5-containing complexes could favor the expression of genes contributing to the high anxiety trait (see Fig. 3 for a working model). NuRD complexes also contain the histone deacetylases HDAC1 and/or HDAC2 [17, 21] . Therefore, we next examined if their expression and that of other HDACs is altered in HAB mice. Using immunoblot experiments with antibodies against HDAC1 (ZymedInvitrogen 34-8300), HDAC2 (Zymed-Invitrogen 34-6400), HDAC3 Compared to NAB mice the expression of CHD3, CHD5 in the ventral hippocampus (vHC; left side) and of SNF2H in the amygdala (right side) of the highly anxious HAB mice is altered. In the vHC, the increased CHD5 but reduced CHD3 levels along with unchanged HDAC1/2 expression may indicate preferential assembly of NuRD-like complexes containing CHD5 in HAB mice and containing CHD3 in NAB mice, respectively. Since NuRD complexes are involved in reorganizing the chromatin structure at gene (promoters) leading primarily to transcriptional repression, a shift from predominantly CHD3-containing NuRD complexes in NAB mice to predominantly CHD5-containing NuRD complexes in HAB mice may cause a switch in the transcriptional programs in the vHC, thus promoting higher anxiety states. At the same time, HAB mice have lower levels of SNF2H in the amygdala than NAB mice. SNF2H complexes generally attenuate transcription by nucleosome assembly and sliding, and the reduced levels of amygdaloid SNF2H protein may lead to lower amounts of (certain) SNF2H-containing complexes. Consequently, transcriptional processes at target genes that are sensitive to SNF2H (right side) may be affected. It is important to note, however, that in knock-out or knock-down studies with SNF2H, CHD3 and CHD5, also transcriptional upregulation of genes has been observed. Thus, we hypothesize that a switch of NuRD-like complexes in the ventral hippocampus and concomitant lower levels of SNF2H in the amygdala of HAB compared to NAB mice may result in different transcriptional read-outs in both brain areas, thereby contributing to the manifestation of different anxiety behavior in these mouse lines. Different gene expression profiles are designated "gene sets A-J" and symbolized as red bars for transcriptional repression and green bars for activation in the graphical model.
(Zymed-Invitrogen 34-7700) and HDAC6 (Zymed-Invitrogen Z30197), we found similar protein levels of each enzyme in HAB and NAB mice in the brain regions tested (Table 1 ). This lack of difference of HDAC1 and HDAC2 expression between HAB and NAB mice is consistent with the idea that the composition rather than the amount of NuRD complexes in the ventral hippocampus is altered in HAB compared to NAB mice (Fig. 3) . It is important to note, however, that HDACs are components of various distinct chromatin modification complexes apart from the NuRD complexes. At this point, we cannot exclude the possibility of changes in their relative distribution among these complexes in HAB versus NAB mice.
Beside the ventral hippocampus, the amygdala was the only other brain region, where we detected differences in ChRF expression. Specifically, the expression of SNF2H was attenuated in HAB vs NAB mice. The amygdala is strongly connected with the ventral hippocampus and plays a key role in circuitries processing anxiety and fear [23] . For example, amygdala hyperactivation has been reported for several anxiety-and trauma-related disorders like posttraumatic stress disorder, specific and social phobia, generalized anxiety disorder or panic disorder [3] . Since HAB mice have been shown to display amygdala hyperactivation in response to a stressful experience [24] , lower levels of amygdaloid SNF2H may contribute to a dysregulation of gene programs involved in modulating the activity state of amygdala neurons in HAB mice (Fig. 3) . SNF2H is the catalytic subunit of several different complexes that have been linked to various cellular processes, such as replication, DNA repair and transcription [25] . Two previous reports suggested a link between SNF2H and anxiety: Altered expression of the SNF2H-containing ACF remodeling complex in the nucleus accumbens resulted in increased depressive-like and increased anxiety behavior (tested by EPM) in mice [26] , and deletion of the transcription factor WSTF, which partners SNF2H in the WICH complex, causes Williams Syndrome, a human disorder characterized by high prevalence of anxiety [27] . To determine if reduced SNF2H levels in the amygdala of HAB mice are accompanied by lower WICH levels, we performed western blot analysis for WSTF expression, which unfortunately turned out to be inconclusive due to inferior antibody quality. qPCR analysis of Wstf transcript levels in the amygdala, however, revealed no differences between HAB and NAB mice (data not shown).
Taken together, our results provide the first evidence for an association between ATP-dependent chromatin remodeling factor levels in distinct brain areas and the manifestation of high trait anxiety. Future studies using the HAB and NAB mouse models to characterize the gene sets affected by the dysregulation of SNF2H, CHD3 and CHD5 should help to elucidate the molecular mechanisms underlying a genetic disposition to anxiety disorders and may uncover novel strategies for therapeutic intervention.
